U.S. Transportation Stock News

Keysight Technologies (NYSE:KEYS) introduced new RF and Electrical-Optical-Electrical simulation tools, presented through live demos at recent industry events. The launch includes an executable whiteboard for RF design automation that captures and automates engineering workflows. Keysight also rolled out an integrated EOE simulation workflow in its ADS 2026 platform, aimed at unified analysis for AI, quantum, and optical networking applications. Keysight Technologies, known for its...

Patterson-UTI Energy (NasdaqGS:PTEN) completed a US$500 million senior notes offering. The company plans to use the proceeds to redeem earlier, lower-yielding notes and for general corporate purposes. The transaction represents a significant refinancing step that could affect interest costs and balance sheet flexibility. Patterson-UTI Energy, a contract drilling and oilfield services company, operates in a sector where access to capital can matter almost as much as rig count. Refinancing...

Pitney Bowes (NYSE:PBI) has opened a new 75,000-square-foot Presort Services operating center in Phoenix. The highly automated facility expands the company’s processing capacity and operational footprint in the region. For investors tracking NYSE:PBI, the Phoenix launch adds fresh context to a stock that has seen very large gains over the past 3 years and is up 55.9% year to date. The current share price sits at $16.1, with the stock up 5.6% over the past week and 61.3% over the past year,...

If you are wondering whether Cellebrite DI stock offers good value at today’s prices, the key is to understand how that price compares with what the business might reasonably be worth. The share price last closed at US$14.73, after gaining 11.8% over the past week and 10.3% over the past month, while being down 17.4% year to date and down 11.7% over the last year, with a very large 3 year gain and a 48.8% gain over 5 years. Recent trading has been shaped by ongoing interest in Cellebrite...

Innoviva (NasdaqGS:INVA) has appointed former Goldman Sachs partner Josephine Linden to its Board following two director resignations linked to work with Syndeio BioSciences. The departing directors are expected to focus on Syndeio BioSciences, a company in which Innoviva invests and intends to support. Innoviva has also highlighted a newly approved gonorrhea treatment that it plans to launch later this year. For investors watching NasdaqGS:INVA, these board changes arrive alongside an...

LyondellBasell Industries (NYSE:LYB) has filed a shelf registration for 8,000,000 ordinary shares tied to an employee stock ownership plan. The filing allows the company to issue these shares over time as part of its ESOP related offering. The move highlights an ongoing focus on equity based compensation and its role in LyondellBasell's capital structure. LyondellBasell is a global chemicals and plastics company, and its stock sits at the intersection of industrial activity, energy markets,...

In late May 2026, Sweetgreen, Inc. appointed former Chipotle executive Cindy Olsen as its first SVP, Chief Strategy Officer, reporting directly to CEO Jonathan Neman to lead corporate strategy and strategic communications under the Sweet Growth Transformation Plan. By combining restaurant-operator experience with nearly two decades as a consumer-sector equity analyst, Olsen brings an investor-focused lens to how Sweetgreen sets priorities, measures execution, and explains its long-term...

TETRA Technologies' Board has conditionally approved the final investment decision for its Evergreen bromine production facility. The Evergreen project aims to support vertical integration and domestic bromine supply security for TETRA Technologies. This decision is described by the company as a key milestone within its ONE TETRA 2030 plan. TETRA Technologies (NYSE:TTI) is moving ahead with the Evergreen bromine facility at a time when its stock has shown strong multiyear returns, including...

Magnachip Semiconductor (MX) has drawn fresh investor attention after announcing plans to showcase its Medium Voltage MOSFET portfolio for AI server and data center power systems at PCIM Europe 2026 in Nuremberg. See our latest analysis for Magnachip Semiconductor. The latest AI server and data center announcement lands after a strong run in the stock, with a 90 day share price return of 220% and a 1 year total shareholder return of 143.77%, although the 5 year total shareholder return shows...

REalloys (NasdaqCM:ALOY) signed a non binding Memorandum of Understanding with Ramaco Resources to source rare earth and critical minerals from the Brook Mine in Wyoming. The framework focuses on using domestic feedstock to support North American supply chains for defense, advanced manufacturing, and energy infrastructure. The arrangement is intended to use existing mining infrastructure at Brook Mine for potential future development of unconventional rare earth sources. For you as an...

Copart is seeing stronger international growth and a broader global buyer network support higher auction returns. These trends are helping offset softer U.S. insurance volumes highlighted in recent quarterly commentary. The update sheds light on how Copart is using its global reach to support its core auction business. Copart (NasdaqGS:CPRT), trading at $32.77 at the last close, is contending with weaker U.S. insurance volumes while leaning more on its overseas operations. The stock is down...

Dynagas LNG Partners (DLNG) opened Q1 2026 with total revenue of US$39.9 million and basic EPS of US$0.48, against a trailing twelve month EPS of US$1.49 on US$157.5 million of revenue and earnings growth of 34.3% over the past year. Over recent quarters the partnership has seen revenue move in a relatively tight band between US$38.6 million and US$41.7 million per quarter, while quarterly EPS has ranged from US$0.03 to just above US$0.51. This has fed into a trailing net margin of 34.5%,...

Coursera (NYSE:COUR) has announced a $500 million share repurchase program. The buyback authorizes the company to repurchase its common stock over time, subject to market conditions and other factors. The decision comes as the stock most recently closed at $5.39. For investors watching NYSE:COUR, the buyback plan comes after a difficult stretch for the stock. Coursera shares are down 23.9% year to date and 39.1% over the past year, with a 59.1% decline over three years and 86.4% over five...

If you are wondering whether Capri Holdings trades at a fair price or offers value, it helps to start with how the market has treated the stock recently and what that says about expectations. The share price closed at US$18.51, with a 0.2% gain over the last week, a decline of 5.7% over the last month, a decline of 24.1% year to date, a 2.2% gain over the last year, a decline of 48.7% over three years, and a decline of 65.6% over five years. Recent coverage around Capri Holdings has focused...

Maximus (NYSE:MMS) amended its credit agreement to add $325 million to its existing term B loans. The company plans to use the new debt for share repurchases, working capital, and repayment of existing debt. Maximus, trading at $61.93, is taking on additional term B loan financing that directly affects how it allocates capital between shareholders and creditors. The move comes after the stock declined 28.4% year to date and 13.1% over the past year, with a 22.0% decline over three years and...

HomesToLife (HTLM) has opened 2026 with Q1 revenue of US$92.5 million and basic EPS of US$0.04. Trailing twelve month revenue sits at US$390.9 million and EPS at US$0.19, framing a business that is currently earning at a higher run rate than any single recent quarter. The company has seen revenue move from US$335.1 million and EPS of US$0.09 on a trailing basis in Q4 2024 to US$390.9 million and EPS of US$0.19 by Q1 2026. This has occurred alongside a trailing net profit margin of 4.5% and...

World Health Organization recommends Regeneron’s maftivimab for priority evaluation in clinical trials for the current Bundibugyo ebolavirus outbreak. Maftivimab is a component of Inmazeb, which is already approved for Zaire ebolavirus treatment. The recommendation positions Regeneron Pharmaceuticals (NasdaqGS:REGN) within an active emergency response affecting multiple African countries. Regeneron Pharmaceuticals, traded as NasdaqGS:REGN, is widely known for its antibody platforms and...

In late May 2026, Safe Pro Group Inc. announced progress in its AI-powered threat detection collaboration with Lantronix, integrating Safe Pro’s algorithms into Lantronix’s Open-Q System-on-Module platform for real-time edge processing across drones and autonomous systems. This work, already tied to Qualcomm-based platforms and U.S. Army Short Range Reconnaissance drones under a Master Services Agreement, underscores Lantronix’s role in enabling NDAA-compliant, on-device AI for defense and...

QTREX Quantum Ltd., formerly Inspira Technologies Oxy B.H.N. Ltd., recently agreed to a US$10,000,000 private placement of 6,666,667 ordinary shares and earlier announced a US$580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems. Together with the upcoming ticker change to “QTEX” on the Nasdaq Capital Market, these moves highlight fresh institutional interest and early clinical adoption of the ART100 platform by a...

Securities class action lawsuit filed against Zoetis (NYSE:ZTS) and certain executives alleging misleading statements about product safety and demand in the Companion Animal division. Claims focus on disclosures around veterinarian adoption, competitive pressures, and demand trends for key Companion Animal products. The suit alleges that weakening prescriptions, new competition, and slowing demand were not fully communicated before guidance cuts. Zoetis, trading at $77.69, is facing this...

FDA has granted Priority Review for BridgeBio Pharma's BBP-418 for limb-girdle muscular dystrophy type 2I/R9. If approved, BBP-418 could become the first and only therapy for LGMD2I/R9 and the first treatment for any form of LGMD. The Priority Review follows acceptance of BridgeBio's NDA and is tied to plans for a near-term commercial launch. For investors following BridgeBio Pharma (NasdaqGS:BBIO), this regulatory step sits alongside a share price of $66.26, a 3-year return of around 4x,...

Humacyte recently reported research from its acellular tissue engineered vessel (ATEV) program showing long-term structural integrity and self-repair after years of repeated dialysis cannulation, alongside reduced infection susceptibility versus ePTFE grafts, and confirmed that top-line Phase 3 V012 dialysis access results are scheduled for release on June 11, 2026. Together with ongoing late-stage trials and an approved vascular trauma indication, the ATEV’s self-repair profile highlights...

Buckle (BKE) opened Q1 2027 with revenue of US$288.7 million and basic EPS of US$0.93, setting the tone against a trailing twelve month backdrop of US$1.3 billion in revenue and basic EPS of US$4.40. Over the past year, the company has seen quarterly revenue move from US$272.1 million in Q1 2026 to US$399.1 million in Q4 2026 before landing at US$288.7 million in the latest quarter, while basic EPS ranged from US$0.70 to US$1.60 over the same stretch, giving investors a clear read on how top...

Willis Towers Watson (NasdaqGS:WTW) has announced new leadership appointments in its FINEX North America business to sharpen its cyber strategy. The moves include a new Head of Cyber and roles focused on executing cyber plans and deepening client engagement across North America. The changes come as AI driven risk, governance concerns, and cyber threats draw increased attention across the insurance and risk advisory sector. For investors following NasdaqGS:WTW, these appointments sit at the...